Financial Highlights as at 30 June 2024
Share Price
$0.8400
Ordinary Shares in issue with voting rights
1,219.1m
Shares in Treasury
154.8m
NAV per Share
$1.0074
Discount to NAV per Share
16.6%
Net Assets
$1,228.1m
A Unique London-Listed Investment Company, Providing Access to Debt Capital for the Life Sciences Industry
BioPharma Credit PLC's primary objective is to generate predictable income for shareholders over the long term.